QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module XVI — Risk Minimisation Measures

Test your understanding of the concepts covered by GVP Module XVI: Risk Minimisation Measures.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate relationship between signal management and risk minimisation?

Every signal automatically requires an additional risk minimisation measure Signal management provides safety evidence that may prompt reassessment, while risk minimisation translates an established intervention need into action Risk minimisation replaces signal management once a measure is introduced Signals are relevant only to routine risk minimisation

Question 2 of 10 Which design principle is most appropriate when patients are expected to recognise and report a symptom associated with a serious risk?

Provide highly technical information and leave the response decision entirely to the patient Use understandable, focused information that explains the required action while retaining professional responsibility where clinical assessment is needed Avoid involving patients because risk minimisation is solely a healthcare-professional activity Require patients to independently diagnose the adverse reaction before seeking advice

Question 3 of 10 Which consideration best reflects proportionality in risk minimisation?

The most restrictive measure should always be selected for the most serious risk The burden of the intervention should be balanced against the consequences of inadequate risk control Administrative simplicity is always more important than risk severity A measure is proportionate if it is approved by a competent authority

Question 4 of 10 Which situation most clearly supports the use of a controlled-access measure?

The safety concern is general and adequately addressed by standard product information Exposure should occur only after defined eligibility or monitoring criteria have been satisfied The MAH wants to demonstrate that it has taken visible action The product has a large target population with no specific exposure conditions

Question 5 of 10 Which sequence best represents the conceptual levels of effectiveness evaluation described in the article?

Distribution, regulatory approval, budgeting, discontinuation Implementation, behavioural change, appropriate exposure change, clinical outcome and attribution Clinical outcome, distribution, training completion, product launch Training completion, material approval, signal detection, marketing performance

Question 6 of 10 A study finds fewer adverse events after a risk minimisation programme begins. Why should the company avoid immediately attributing the reduction to the programme?

Clinical outcomes are never relevant to risk minimisation evaluation A reduction in events may reflect changes in exposure, disease incidence, prescribing, guidelines or other interventions Only distribution data can be used in effectiveness evaluation Attribution is possible only through a randomised clinical trial

Question 7 of 10 A proposed risk minimisation measure is documented separately from the risk management plan, with no clear link to the safety concern or effectiveness evaluation. What is the principal weakness?

The measure is automatically invalid because all measures must be educational The absence of a coherent link prevents traceability from the risk through implementation to evaluation Risk minimisation measures must never be documented outside the product information The measure should be transferred entirely to the clinical department

Question 8 of 10 A monitoring requirement specifies that a laboratory test must be performed but does not explain how results should be interpreted or what action follows an abnormal result. What is the likely concern?

Testing is never an appropriate risk minimisation measure The requirement may not provide meaningful risk control because the clinical response is undefined The measure automatically becomes routine risk minimisation The absence of a patient leaflet is the only relevant deficiency

Question 9 of 10 Several complementary measures address the same safety concern. What is the most appropriate evaluation approach?

Evaluate only the measure that was implemented first Assume that every component contributed equally Assess whether the combined strategy works and, where feasible, examine the contribution of individual components Treat the measures as unrelated and exclude their interaction from interpretation

Question 10 of 10 Why should unintended consequences be included in the evaluation of a restrictive risk minimisation programme?

They are irrelevant if the programme has regulatory approval Restrictions may delay appropriate treatment, create workarounds or shift use toward alternatives with different risks They demonstrate that the original safety concern was incorrect They eliminate the need to evaluate the intended risk reduction

Knowledge Assessment: GVP Module XVI — Risk Minimisation Measures

Cookie Settings